84 related articles for article (PubMed ID: 16793377)
21. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
22. Insights into protein - DNA interactions, stability and allosteric communications: a computational study of mutSα-DNA recognition complexes.
Negureanu L; Salsbury FR
J Biomol Struct Dyn; 2012; 29(4):757-76. PubMed ID: 22208277
[TBL] [Abstract][Full Text] [Related]
23. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
[TBL] [Abstract][Full Text] [Related]
24. YB-1 disrupts mismatch repair complex formation, interferes with MutSα recruitment on mismatch and inhibits mismatch repair through interacting with PCNA.
Chang YW; Mai RT; Fang WH; Lin CC; Chiu CC; Wu Lee YH
Oncogene; 2014 Oct; 33(43):5065-77. PubMed ID: 24141788
[TBL] [Abstract][Full Text] [Related]
25. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Aebi S; Fink D; Gordon R; Kim HK; Zheng H; Fink JL; Howell SB
Clin Cancer Res; 1997 Oct; 3(10):1763-7. PubMed ID: 9815561
[TBL] [Abstract][Full Text] [Related]
26. MutSα maintains the mismatch repair capability by inhibiting PCNA unloading.
Kawasoe Y; Tsurimoto T; Nakagawa T; Masukata H; Takahashi TS
Elife; 2016 Jul; 5():. PubMed ID: 27402201
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
29. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
30. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair.
Oki E; Oda S; Maehara Y; Sugimachi K
Oncogene; 1999 Mar; 18(12):2143-7. PubMed ID: 10321739
[TBL] [Abstract][Full Text] [Related]
31. Measurement of DNA mismatch repair activity in live cells.
Lei X; Zhu Y; Tomkinson A; Sun L
Nucleic Acids Res; 2004 Jul; 32(12):e100. PubMed ID: 15249596
[TBL] [Abstract][Full Text] [Related]
32. Induction of aberrant crypt foci in DNA mismatch repair-deficient mice by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP).
Smith-Roe SL; Löhr CV; Bildfell RJ; Fischer KA; Hegan DC; Glazer PM; Buermeyer AB
Cancer Lett; 2006 Nov; 244(1):79-85. PubMed ID: 16427736
[TBL] [Abstract][Full Text] [Related]
33. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
[TBL] [Abstract][Full Text] [Related]
34. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
35. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
36. Non-specificity and synergy at the binding site of the carboplatin-induced DNA adduct via molecular dynamics simulations of the MutSα-DNA recognition complex.
Negureanu L; Salsbury FR
J Biomol Struct Dyn; 2014; 32(6):969-92. PubMed ID: 23799640
[TBL] [Abstract][Full Text] [Related]
37. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network.
Bindra RS; Glazer PM
Cancer Lett; 2007 Jul; 252(1):93-103. PubMed ID: 17275176
[TBL] [Abstract][Full Text] [Related]
38. Human cells bearing homozygous mutations in the DNA mismatch repair genes hMLH1 or hMSH2 are fully proficient in transcription-coupled nucleotide excision repair.
Rochette PJ; Bastien N; McKay BC; Therrien JP; Drobetsky EA; Drouin R
Oncogene; 2002 Aug; 21(37):5743-52. PubMed ID: 12173044
[TBL] [Abstract][Full Text] [Related]
39. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
